Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFRα Human Monoclonal Antibody, in Patients With Advanced and/or Metastatic Cancer
Clinical Pharmacokinetics - United Kingdom
doi 10.1007/s40262-017-0562-0
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 15, 2017
Authors
Publisher
Springer Science and Business Media LLC